Caryn G. McDowell's most recent trade in Quince Therapeutics Inc was a trade of 10,800 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on June 6, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Sale of securities on an exchange or to another person at price $ 2.86 per share. | 06 Jun 2022 | 10,800 | 122,500 (0%) | 0% | 2.9 | 30,923 | Common Stock |
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.86 per share. | 06 Jun 2022 | 6,700 | 133,300 (0%) | 0% | 2.9 | 19,183 | Common Stock |
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 140,000 | 140,000 (0%) | 0% | 0 | Common Stock | |
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Caryn G. McDowell | Chief Legal & Adm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |